Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cholesterol, statins and dementia.

Benjamin Wolozin1

  • 1Department of Pharmacology, Boston University School of Medicine, L-603, Boston, MA 02118-2526, USA. bwolozin@bu.edu

Current Opinion in Lipidology
|November 6, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ribosome impairment, tau alternative splicing, and stress granules: a convergent axis of neuronal vulnerability driving Alzheimer's disease.

European journal of pharmacology·2026
Same author

circPDE4B downregulation triggers GEMIN5‑dependent translational stress response and autophagy to reduce MAPT pathology.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

The loss of Tau in the adult brain triggers neuroplastic, epigenetic and behavioral deficits.

bioRxiv : the preprint server for biology·2026
Same author

The striatal heterogeneous nuclear ribonucleoprotein H1 mRNA targetome associated with methamphetamine administration and behavior.

Progress in neuro-psychopharmacology & biological psychiatry·2025
Same author

Nanobodies targeting hnRNPA2/B1 and tau.

bioRxiv : the preprint server for biology·2025
Same author

RNA Granules at the Crossroads of Synaptic Dysfunction and Neurodegeneration.

Journal of neurochemistry·2025
Same journal

Editorial introduction.

Current opinion in lipidology·2026
Same journal

Heterozygosity for pathogenic variants in familial chylomicronemia syndrome genes: from carrier state to complex trait.

Current opinion in lipidology·2026
Same journal

Premature atherosclerotic cardiovascular disease in the MENA region: economic impact, barriers to care, and policy recommendations for an escalating crisis.

Current opinion in lipidology·2026
Same journal

The role of metabolic profiling and dietary intervention in the early diagnosis and prevention of atherosclerosis.

Current opinion in lipidology·2026
Same journal

A JAK of two trades: beneficial or adverse effects of Janus kinase inhibition for plasma LDL-cholesterol and major adverse cardiovascular events in inflammatory bowel disease patients?

Current opinion in lipidology·2026
Same journal

Inflammation and atherosclerotic cardiovascular disease: where do we go from here?

Current opinion in lipidology·2026
See all related articles

Cholesterol metabolism influences Alzheimer's disease pathology. While statins show promise, current evidence suggests they primarily offer neuroprotection rather than directly reducing beta-amyloid production in humans.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Genetics

Background:

  • Cholesterol metabolism is increasingly recognized for its role in modulating beta-amyloid production.
  • A strong link between cholesterol and Alzheimer's disease (AD) is supported by genetic and cell biology studies.

Purpose of the Study:

  • To review recent advances in understanding the relationship between cholesterol and Alzheimer's disease.
  • To evaluate the therapeutic potential of cholesterol-modulating pharmaceuticals in AD.

Main Methods:

  • Review of current literature in genetics, cell biology, and clinical sciences.
  • Analysis of studies investigating cholesterol's impact on amyloid precursor protein processing.

Main Results:

Related Experiment Videos

  • Cholesterol, its metabolites, and regulatory proteins influence amyloid precursor protein processing.
  • Clinical studies indicate that animal models may not fully translate to human responses regarding cholesterol and AD.
  • Statins demonstrate potential in Alzheimer's disease therapy.

    • Conclusions:

    • Cholesterol plays a significant role in modulating amyloid precursor protein processing.
    • Statins may act as neuroprotective agents in Alzheimer's disease.
    • The current data suggest statins are more effective as neuroprotectants than as direct inhibitors of beta-amyloid production.